CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Stocks that are likely to record significant movement on bourses today
Karan Dsij
/ Categories: Trending

Stocks that are likely to record significant movement on bourses today

Hatsun Agro Products: The newly-commissioned milk and milk products plant in Solapur (Maharashtra), with a milk handling capacity of 6 LLPD, begins its commercial production.  

Mahindra CIE: The company has been taking various steps to optimise its power cost and increase the consumption of green energy at various power intense plants of the company. Accordingly, the company subscribed to 8,26,000 equity shares of ReNew Surya Alok Private Limited, which constitute 31.20 per cent of the total issued and paid-up capital of ReNew. 

Infosys: Infosys has been recognised as one of the world's most ethical companies by Ethisphere Institute. 

TCS: The company has been recognised as a leader in system integrator capabilities on AWS by Everest Group. 

Sun Pharma: Sun Pharma to introduce a complete range of Brivaracetam at an affordable price for epilepsy treatment in India.   

Sun Pharma Advanced Research Company: Office of New Drugs (OND) of United States Food & Drug Administration (USFDA) has denied the company’s appeal of the complete response letter in relation to the new drug application (NDA) for Taclantis™. In its appeal denied letter, the OND requested the conduct of a new phase 3 study in metastatic breast cancer patients to support any potential resubmission of the Taclantis™ NDA. The company will review FDA’s response and decide on appropriate next steps soon. 

Sanghi Cement: The outstanding non-convertible debentures (NCD) of the company amounts to Rs 305 crore, which was issued on February 23, 2021. 

REC: Issue of US$ 500 million 2.25 per cent notes by REC. 

NTPC: NTPC Ltd has executed share purchase agreements with GAIL (India) Ltd for the purchase of GAIL’s share (25.51 per cent) in Ratnagiri Gas & Power Pvt Ltd (RGPPL) as well as the sale of NTPC's share (14.82 per cent) (on a fully-dilutive basis) in Konkan LNG Ltd (KLL). 

Previous Article NSE semi-annual review: Tata Consumer Products replaces GAIL in Nifty 50; 24 stocks get replaced in Nifty 500
Next Article 9.11 Ratios & market prices
Print
993 Rate this article:
4.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR